Publication of Financial Statements 2024/25

Summary by AI BETAClose X

Midland Heart Capital PLC published its 2024/25 financial statements, reporting a turnover of £243.1 million, an increase of £11.2 million compared to the previous year. The total surplus increased to £25.5 million, mainly due to the sale of 23 supported housing schemes. Key investments included £108 million in new affordable homes and £35 million in improving existing homes, encompassing over 2,000 kitchen and bathroom upgrades, 670 window replacements, and 260 roof replacements.

Disclaimer*

Midland Heart Capital PLC
18 August 2025
 

Midland Heart - Publication of Financial Statements 2024/25

Midland Heart has published another robust set of financial results for the last 12 months, shortly after unveiling plans to invest a record £300m on upgrading its homes. 

In 2024/25, Midland Heart reported an annual turnover of £243.1m, an increase of £11.2m on the previous year and an increased total surplus of £25.5m, driven largely by the sale of 23 supported housing schemes to a specialist Extra Care and Retirement Living provider.

Highlights include:

-     £108m was invested in building new affordable homes for tenants

-     £35m was invested in improving existing homes, including upgrading over 2,000 new kitchens and bathrooms, and replacing approximately 670 windows and 260 roofs.

Click to read the annual report in full.

For further information, please contact media@midlandheart.org.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings